May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for clinicians now recommend considering fluoroestradiol (FES) positron emission tomography (PET) for systemic staging in patients with recurrent or metastatic lobular breast cancer.

May 29, 2025 — Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — the Swoop system — has announced FDA clearance of its next-generation software.

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently announced that its flagship product, DL Precise, is now in commercial use at major healthcare institutions across the United States, including Cleveland Clinic, AdventHealth, Mayo Clinic, Geisinger and others.

This marks the continuation of DeepLook’s commercial rollout, following successful pilots and initial data confirming the platform’s potential to support clinical performance and streamline imaging workflows.

May 20, 2025 — Royal Philips has launched  the RADIQAL (Radiation Dose and Image Quality Trial) trial. This multicenter, randomized study, sponsored by Philips will enroll 824 coronary artery disease patients across 6 hospitals in Spain, Czech Republic and the US. The first patient in the study was enrolled at Aarhus University Hospital, Denmark.

May 20, 2025 – Intelerad, a provider of medical imaging software solutions, recently announced its prime partnership with RADPAIR, a provider of generative AI-driven radiology solutions, to deliver an enhanced radiology reporting experience.

May 21, 2025 — Konica Minolta Healthcare Americas, Inc and NewVue have announced the introduction of Exa Teleradiology, Powered by NewVue to meet the complex needs of modern teleradiology groups. Designed specifically for distributed reading environments, Exa Teleradiology will streamline the reading experience across multiple systems and facilities, including imaging centers, all delivered through a single cloud-based solution that leverages deeper points of integration than standard interfaced solutions.

May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pediatric patients, giving cardiologists a fuller picture of ventricular function when assessing possible heart abnormalities or disease. 

May 19, 2025 - Arineta, a provider of cardiovascular imaging solutions, recently announced that its SpotLight Duo cardiac CT scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for low-dose lung cancer screening (LDCT). This clearance allows providers to use a single ultra-fast CT platform for both cardiac and lung imaging and diagnostics, delivering more complete care to high-risk patients.

May 15, 2025 – Royal Philips, a global leader in health technology, has released its 10th annual Future Health Index (FHI) report, highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery.

May 14, 2025 – Bialogics Analytics Inc., a leader in radiology informatics, has introduced its new AI solution AI Quality Framework (AIQ), a first-of-its-kind, evidence-driven framework for continuous, real-time assessment of AI systems in diagnostic imaging.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now